Chicago Partners Investment Group LLC Takes $925,000 Position in Molina Healthcare, Inc $MOH

Chicago Partners Investment Group LLC acquired a new stake in Molina Healthcare, Inc (NYSE:MOH) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 6,936 shares of the company’s stock, valued at approximately $925,000.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Torren Management LLC acquired a new position in shares of Molina Healthcare during the fourth quarter worth approximately $26,000. Miller Global Investments LLC purchased a new position in shares of Molina Healthcare during the fourth quarter valued at approximately $27,000. Physician Wealth Advisors Inc. raised its position in Molina Healthcare by 1,250.0% in the 1st quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock valued at $29,000 after buying an additional 200 shares during the last quarter. Cromwell Holdings LLC raised its holdings in shares of Molina Healthcare by 211.9% in the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock valued at $32,000 after purchasing an additional 125 shares during the last quarter. Finally, Quarry LP purchased a new stake in shares of Molina Healthcare during the fourth quarter valued at approximately $32,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the transaction, the insider directly owned 67,175 shares in the company, valued at $12,502,611. This represents a 20.96% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the sale, the chief accounting officer directly owned 12,815 shares in the company, valued at approximately $2,454,713.25. The trade was a 4.47% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is currently owned by company insiders.

Molina Healthcare Stock Performance

Molina Healthcare stock opened at $225.05 on Friday. The firm’s 50 day simple moving average is $202.64 and its 200 day simple moving average is $175.16. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $244.89. The firm has a market capitalization of $11.72 billion, a PE ratio of 66.58 and a beta of 0.74.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. The firm had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The business’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same period in the previous year, the business earned $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, analysts expect that Molina Healthcare, Inc will post 5.23 earnings per share for the current fiscal year.

Analysts Set New Price Targets

MOH has been the subject of several research analyst reports. Truist Financial raised their target price on Molina Healthcare from $205.00 to $250.00 and gave the company a “hold” rating in a research report on Tuesday. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $129.00 target price on shares of Molina Healthcare in a research report on Friday, April 24th. Morgan Stanley raised their price target on shares of Molina Healthcare from $146.00 to $167.00 and gave the stock an “equal weight” rating in a research note on Thursday, June 4th. Sanford C. Bernstein set a $286.00 price target on shares of Molina Healthcare in a report on Monday. Finally, TD Cowen upped their price objective on Molina Healthcare from $163.00 to $230.00 and gave the company a “hold” rating in a research note on Tuesday. Three research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $207.06.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.